texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x
Request an Appointment

Clinical Publications and Presentations

PUBLICATION TITLE
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
PUBLICATION
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
CITATION
J Clin Oncol. 2020 Mar 1;38(7):706-714
CLINICIANS
Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, Olson MR, Meng J, Paulus R, Curran WJ Jr, Choy H.
PUBLICATION TITLE
Highlights in Metastatic Breast Cancer From the 2019 San Antonio Breast Cancer Symposium: Commentary
PUBLICATION
Clinical Advances in Hematology & Oncology: H&O
CITATION
Clin Adv Hematol Oncol. 2020 Jan;18 Suppl 4(1):17-19
CLINICIANS
O'Shaughnessy JA.
PUBLICATION TITLE
 Covid-19 Associated Coagulopathy
PUBLICATION
Feature Article in the University of Texas Southwestern Covid-19 Action Newsletter
CLINICIANS
Le T, and Ibrahim I
PUBLICATION TITLE
A Randomized Control Trial of Meditation Compared to Music Listening To Improve Cognitive Function for Breast Cancer Survivors: Feasibility and Acceptability
PUBLICATION
Complementary Therapies in Clinical Practice
CITATION
Complement Ther Clin Pract. 2020 Nov;41:101228.
CLINICIANS
Henneghan AM, Becker H, Harrison ML, Inselmann K, Fico B, Schafer H, King E, Patt D, Kesler S.
PUBLICATION TITLE
Sacituzumab Govitecan in Previously Treated Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Final Results From a Phase I/II, Single-Arm, Basket Trial
PUBLICATION
Annals of Oncology: Official Journal of the European Society for Medical Oncology
CITATION
Ann Oncol. 2020 Dec;31(12):1709-1718.
CLINICIANS
Kalinsky K, Diamond JR, Vahdat LT, Tolaney SM, Juric D, O'Shaughnessy J, Moroose RL, Mayer IA, Abramson VG, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Goswami T, Wegener WA, Bardia A.
PUBLICATION TITLE
Final Overall Survival Results From a Phase 3 Study To Compare Tivozanib to Sorafenib As Third- or Fourth-Line Therapy in Subjects With Metastatic Renal Cell Carcinoma
PUBLICATION
European Urology
CITATION
Eur Urol. 2020 Dec;78(6):783-785.
CLINICIANS
Pal SK, Escudier BJ, Atkins MB, Hutson TE, Porta C, Verzoni E, Needle MN, Powers D, McDermott DF, Rini BI.
PUBLICATION TITLE
Association of Pathologic Complete Response With Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis
PUBLICATION
Cancer Research
CITATION
Cancer Res. 2020 Dec 15;80(24):5427-5434.
CLINICIANS
Huang M, O'Shaughnessy J, Zhao J, Haiderali A, Cortés J, Ramsey SD, Briggs A, Hu P, Karantza V, Aktan G, Qi CZ, Gu C, Xie J, Yuan M, Cook J, Untch M, Schmid P, Fasching PA.
PUBLICATION TITLE
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153
PUBLICATION
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
CITATION
J Clin Oncol. 2020 Nov 20;38(33):3863-3873.
CLINICIANS
Waterhouse DM, Garon EB, Chandler J, McCleod M, Hussein M, Jotte R, Horn L, Daniel DB, Keogh G, Creelan B, Einhorn LH, Baker J, Kasbari S, Nikolinakos P, Babu S, Couture F, Leighl NB, Reynolds C, Blumenschein G Jr, Gunuganti V, Li A, Aanur N, Spigel DR.
PUBLICATION TITLE
Recommendations for Patient Similarity Classes: Results of the AMIA 2019 Workshop on Defining Patient Similarity
PUBLICATION
Journal of the American Medical Informatics Association: JAMIA
CITATION
J Am Med Inform Assoc. 2020 Nov 1;27(11):1808-1812.
CLINICIANS
Seligson ND, Warner JL, Dalton WS, Martin D, Miller RS, Patt D, Kehl KL, Palchuk MB, Alterovitz G, Wiley LK, Huang M, Shen F, Wang Y, Nguyen KA, Wong AF, Meric-Bernstam F, Bernstam EV, Chen JL.
PUBLICATION TITLE
An Observational Study of Drug Utilization and Associated Outcomes Among Adult Patients Diagnosed With BRAF-Mutant Advanced Melanoma Treated With First-Line Anti-PD-1 Monotherapies or BRAF/MEK Inhibitors in a Community-Based Oncology Setting
PUBLICATION
Cancer Medicine
CITATION
Cancer Med. 2020 Nov;9(21):7863-7878.
CLINICIANS
Cowey CL, Boyd M, Aguilar KM, Beeks A, Krepler C, Scherrer E.
Displaying results 151-160 (of 1782)
 <  12 13 14 15 16 17 18 19 20 21  > 

* Texas Oncology Clinicians